Global Biologic Therapeutics Market 2023-2027

Description

List of Tables

Technavio has been monitoring the biologic therapeutics market and is forecast to grow by USD 286.12 bn during 2022-2027, accelerating at a CAGR of 11.34% during the forecast period. Our report on the biologic therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of biosimilars, increasing incidence of chronic diseases and immunological disorders, and patent expiry of major biologics.

Technavio's biologic therapeutics market is segmented as below:

By Application

Cancer
Infectious diseases
Autoimmune diseases
Others

By Product

Antibody therapeutics
Vaccines
Cell therapy
Gene therapy
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strong r and d pipeline as one of the prime reasons driving the biologic therapeutics market growth during the next few years. Also, targeted therapeutic mechanism of biologics and increasing investment in developing biologics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biologic therapeutics market covers the following areas:

Biologic therapeutics market sizing
Biologic therapeutics market forecast
Biologic therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologic therapeutics market vendors that include AbbVie Inc., Amgen Inc., Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co. Ltd., Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Precision Biologics Inc., Samsung Electronics Co. Ltd., Sanofi SA, and Tubulis GmbH. Also, the biologic therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Product Code: IRTNTR44341

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global biologic therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global biologic therapeutics market 2017 - 2021 ($ billion)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Cancer - Market size and forecast 2022-2027
Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
6.4 Infectious diseases - Market size and forecast 2022-2027
Exhibit 38: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
6.5 Autoimmune diseases - Market size and forecast 2022-2027
Exhibit 42: Chart on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Autoimmune diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Autoimmune diseases - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ billion)
Exhibit 51: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 52: Chart on Product - Market share 2022-2027 (%)
Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 54: Chart on Comparison by Product
Exhibit 55: Data Table on Comparison by Product
7.3 Antibody therapeutics - Market size and forecast 2022-2027
Exhibit 56: Chart on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Antibody therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Antibody therapeutics - Year-over-year growth 2022-2027 (%)
7.4 Vaccines - Market size and forecast 2022-2027
Exhibit 60: Chart on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Vaccines - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Vaccines - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Vaccines - Year-over-year growth 2022-2027 (%)
7.5 Cell therapy - Market size and forecast 2022-2027
Exhibit 64: Chart on Cell therapy - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Cell therapy - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Cell therapy - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Cell therapy - Year-over-year growth 2022-2027 (%)
7.6 Gene therapy - Market size and forecast 2022-2027
Exhibit 68: Chart on Gene therapy - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Product
Exhibit 76: Market opportunity by Product ($ billion)
Exhibit 77: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 81: Chart on Geographic comparison
Exhibit 82: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 111: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 121: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 123: Overview on factors of disruption
11.4 Industry risks
Exhibit 124: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 125: Vendors covered
12.2 Market positioning of vendors
Exhibit 126: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 127: AbbVie Inc. - Overview
Exhibit 128: AbbVie Inc. - Product / Service
Exhibit 129: AbbVie Inc. - Key news
Exhibit 130: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 131: Amgen Inc. - Overview
Exhibit 132: Amgen Inc. - Product / Service
Exhibit 133: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 134: AstraZeneca Plc - Overview
Exhibit 135: AstraZeneca Plc - Product / Service
Exhibit 136: AstraZeneca Plc - Key news
Exhibit 137: AstraZeneca Plc - Key offerings
12.6 Aurobindo Pharma Ltd.
Exhibit 138: Aurobindo Pharma Ltd. - Overview
Exhibit 139: Aurobindo Pharma Ltd. - Product / Service
Exhibit 140: Aurobindo Pharma Ltd. - Key offerings
12.7 Baxter International Inc.
Exhibit 141: Baxter International Inc. - Overview
Exhibit 142: Baxter International Inc. - Business segments
Exhibit 143: Baxter International Inc. - Key news
Exhibit 144: Baxter International Inc. - Key offerings
Exhibit 145: Baxter International Inc. - Segment focus
12.8 Biocon Ltd.
Exhibit 146: Biocon Ltd. - Overview
Exhibit 147: Biocon Ltd. - Business segments
Exhibit 148: Biocon Ltd. - Key offerings
Exhibit 149: Biocon Ltd. - Segment focus
12.9 Celltrion Healthcare Co. Ltd.
Exhibit 150: Celltrion Healthcare Co. Ltd. - Overview
Exhibit 151: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibit 152: Celltrion Healthcare Co. Ltd. - Key offerings
12.10 Eli Lilly and Co.
Exhibit 153: Eli Lilly and Co. - Overview
Exhibit 154: Eli Lilly and Co. - Product / Service
Exhibit 155: Eli Lilly and Co. - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 156: GlaxoSmithKline Plc - Overview
Exhibit 157: GlaxoSmithKline Plc - Business segments
Exhibit 158: GlaxoSmithKline Plc - Key news
Exhibit 159: GlaxoSmithKline Plc - Key offerings
Exhibit 160: GlaxoSmithKline Plc - Segment focus
12.12 Merck and Co. Inc.
Exhibit 161: Merck and Co. Inc. - Overview
Exhibit 162: Merck and Co. Inc. - Business segments
Exhibit 163: Merck and Co. Inc. - Key news
Exhibit 164: Merck and Co. Inc. - Key offerings
Exhibit 165: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 166: Novartis AG - Overview
Exhibit 167: Novartis AG - Business segments
Exhibit 168: Novartis AG - Key offerings
Exhibit 169: Novartis AG - Segment focus
12.14 Pfizer Inc.
Exhibit 170: Pfizer Inc. - Overview
Exhibit 171: Pfizer Inc. - Product / Service
Exhibit 172: Pfizer Inc. - Key news
Exhibit 173: Pfizer Inc. - Key offerings
12.15 Precision Biologics Inc.
Exhibit 174: Precision Biologics Inc. - Overview
Exhibit 175: Precision Biologics Inc. - Product / Service
Exhibit 176: Precision Biologics Inc. - Key offerings
12.16 Samsung Electronics Co. Ltd.
Exhibit 177: Samsung Electronics Co. Ltd. - Overview
Exhibit 178: Samsung Electronics Co. Ltd. - Business segments
Exhibit 179: Samsung Electronics Co. Ltd. - Key news
Exhibit 180: Samsung Electronics Co. Ltd. - Key offerings
Exhibit 181: Samsung Electronics Co. Ltd. - Segment focus
12.17 Sanofi SA
Exhibit 182: Sanofi SA - Overview
Exhibit 183: Sanofi SA - Business segments
Exhibit 184: Sanofi SA - Key news
Exhibit 185: Sanofi SA - Key offerings
Exhibit 186: Sanofi SA - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 187: Inclusions checklist
Exhibit 188: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 189: Currency conversion rates for US$
13.4 Research methodology
Exhibit 190: Research methodology
Exhibit 191: Validation techniques employed for market sizing
Exhibit 192: Information sources
13.5 List of abbreviations
Exhibit 193: List of abbreviations